학술논문
FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes
Document Type
Article
Author
Source
In: American Journal of Physiology - Endocrinology and Metabolism . (American Journal of Physiology - Endocrinology and Metabolism, August 2022, 323(2):E123-E132)
Subject
Language
English
ISSN
15221555
01931849
01931849